» Articles » PMID: 18286199

Adherent Self-renewable Human Embryonic Stem Cell-derived Neural Stem Cell Line: Functional Engraftment in Experimental Stroke Model

Overview
Journal PLoS One
Date 2008 Feb 21
PMID 18286199
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human embryonic stem cells (hESCs) offer a virtually unlimited source of neural cells for structural repair in neurological disorders, such as stroke. Neural cells can be derived from hESCs either by direct enrichment, or by isolating specific growth factor-responsive and expandable populations of human neural stem cells (hNSCs). Studies have indicated that the direct enrichment method generates a heterogeneous population of cells that may contain residual undifferentiated stem cells that could lead to tumor formation in vivo.

Methods/principal Findings: We isolated an expandable and homogenous population of hNSCs (named SD56) from hESCs using a defined media supplemented with epidermal growth factor (EGF), basic fibroblast growth factor (bFGF) and leukemia inhibitory growth factor (LIF). These hNSCs grew as an adherent monolayer culture. They were fully neuralized and uniformly expressed molecular features of NSCs, including nestin, vimentin and radial glial markers. These hNSCs did not express the pluripotency markers Oct4 or Nanog, nor did they express markers for the mesoderm or endoderm lineages. The self-renewal property of the hNSCs was characterized by a predominant symmetrical mode of cell division. The SD56 hNSCs differentiated into neurons, astrocytes and oligodendrocytes throughout multiple passages in vitro, as well as after transplantation. Together, these criteria confirm the definitive NSC identity of the SD56 cell line. Importantly, they exhibited no chromosome abnormalities and did not form tumors after implantation into rat ischemic brains and into naïve nude rat brains and flanks. Furthermore, hNSCs isolated under these conditions migrated toward the ischemia-injured adult brain parenchyma and improved the independent use of the stroke-impaired forelimb two months post-transplantation.

Conclusions/significance: The SD56 human neural stem cells derived under the reported conditions are stable, do not form tumors in vivo and enable functional recovery after stroke. These properties indicate that this hNSC line may offer a renewable, homogenous source of neural cells that will be valuable for basic and translational research.

Citing Articles

Stem cell therapy as a promising approach for ischemic stroke treatment.

Yaqubi S, Karimian M Curr Res Pharmacol Drug Discov. 2024; 6:100183.

PMID: 38831867 PMC: 11144755. DOI: 10.1016/j.crphar.2024.100183.


Neuroprotection of Stem Cells Against Ischemic Brain Injury: From Bench to Clinic.

Liu X, Jia X Transl Stroke Res. 2023; 15(4):691-713.

PMID: 37415004 PMC: 10771544. DOI: 10.1007/s12975-023-01163-3.


Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects.

Chen X, Jiang S, Wang R, Bao X, Li Y J Alzheimers Dis. 2022; 94(s1):S173-S186.

PMID: 36336934 PMC: 10473082. DOI: 10.3233/JAD-220721.


A Tale of Two: When Neural Stem Cells Encounter Hypoxia.

Fan Y, Li J, Fang B Cell Mol Neurobiol. 2022; 43(5):1799-1816.

PMID: 36308642 PMC: 11412202. DOI: 10.1007/s10571-022-01293-6.


Lipoic acid enhances survival of transplanted neural stem cells by reducing transplantation-associated injury.

Gao J, Thonhoff J, Dunn T, Wu P J Neurorestoratology. 2022; 1:1-12.

PMID: 35663360 PMC: 9162033. DOI: 10.2147/jn.s43745.


References
1.
Evans M, Kaufman M . Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819):154-6. DOI: 10.1038/292154a0. View

2.
Johe K, Hazel T, Muller T, McKay R . Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev. 1996; 10(24):3129-40. DOI: 10.1101/gad.10.24.3129. View

3.
Xu R, Peck R, Li D, Feng X, Ludwig T, Thomson J . Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005; 2(3):185-90. DOI: 10.1038/nmeth744. View

4.
Bendall S, Stewart M, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T . IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature. 2007; 448(7157):1015-21. DOI: 10.1038/nature06027. View

5.
Bliss T, Guzman R, Daadi M, Steinberg G . Cell transplantation therapy for stroke. Stroke. 2007; 38(2 Suppl):817-26. DOI: 10.1161/01.STR.0000247888.25985.62. View